Hepatitis C in 2017: Improved treatment access and frontline realities

Event Date: 
26 July 2017, 13:00 EDT

This past year has been a game changer for hepatitis C in Canada. Most notably, in February of 2017, the pan-Canadian Pharmaceutical Alliance (pCPA), negotiated an agreement with several pharmaceutical companies to lower prices for six hepatitis C medications, on behalf of the provinces and territories. As a result, British Columbia, Alberta, Saskatchewan, Ontario, Quebec and Nova Scotia have broadened access to these Hep C treatments.

This webinar, held in honour of World Hepatitis Day, will review some of the major Hep C developments of 2017; and participants will hear from healthcare providers about how changes in treatment access are affecting front-line realities. 


  • Scott Anderson, Hepatitis C Researcher/Writer, CATIE
  • Dr. Alexandra King, Physician/Researcher, Lu’ma Medical Centre, Vancouver, B.C.
  • Dr. Lisa Barrett, Physician/Researcher, Dalhousie University, Halifax, N.S.
  • Tara Zeagman, Clinical Nurse, Centre SIDA Amitié, St. Jerome, Que.
Powerpoint/PDF File: